FDA approves Teva's generic of Mylan's EpiPen
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs.
from Reuters: Health News https://reut.rs/2MRsV6K
http://bit.ly/2zwRqiM
August 16, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on August 16, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.